[Anticoagulation impact on bleeding risk during HoLEP: Monocentric study of 156 patients].
CONCLUSION: Anticoagulation during HoLEP is a valid option but need to be proceed with carefully management.
LEVEL OF PROOF: 4.
PMID: 29203157 [PubMed - as supplied by publisher]
Source: Progres en Urologie - Category: Urology & Nephrology Tags: Prog Urol Source Type: research
More News: Bladder Catheterization | Bleeding | Clopidogrel | Plavix | Statistics | Study | Urology & Nephrology